Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer.

ABSTRACT:

Objective

Patients with intermediate-risk cervical cancer receive external beam radiotherapy (EBRT) as adjuvant treatment. It is commonly administered with brachytherapy without proven benefits. Therefore, we evaluated the frequency of brachytherapy use, the doses for EBRT administered alone or with brachytherapy, and the overall survival impact of brachytherapy in patients with intermediate-risk, early-stage cervical cancer.

Methods

This retrospective cohort study was performed using data collected from the National Cancer Database. Patients diagnosed with cervical cancer from 2004 to 2019 who underwent a radical hysterectomy and lymph node staging and had disease limited to the cervix but with tumors larger than 4 cm or ranging from 2 to 4 cm with lymphovascular space inva

SUBMITTER: Agusti N 

PROVIDER: S-EPMC11540235 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature